Genomic profiling of ESCC tumors found 98% patients having amplification in one or more cancer‐relevant genes, as well as the co‐amplification of genes at adjacent chromosome locations, such as CCND1/FGF19 and TERC/SOX2/PIK3CA. Here, SOX2 is linked to cancer.